These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 28145409)

  • 1. Treatment of Bipolar Depression with Deep TMS: Results from a Double-Blind, Randomized, Parallel Group, Sham-Controlled Clinical Trial.
    Tavares DF; Myczkowski ML; Alberto RL; Valiengo L; Rios RM; Gordon P; de Sampaio-Junior B; Klein I; Mansur CG; Marcolin MA; Lafer B; Moreno RA; Gattaz W; Daskalakis ZJ; Brunoni AR
    Neuropsychopharmacology; 2017 Dec; 42(13):2593-2601. PubMed ID: 28145409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Deep Transcranial Magnetic Stimulation in Office Workers with Treatment-Resistant Depression: A Randomized, Double-Blind, Sham-Controlled Trial.
    Matsuda Y; Kito S; Igarashi Y; Shigeta M
    Neuropsychobiology; 2020; 79(3):208-213. PubMed ID: 31955155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Active vs Sham Intermittent Theta Burst Transcranial Magnetic Stimulation for Patients With Bipolar Depression: A Randomized Clinical Trial.
    McGirr A; Vila-Rodriguez F; Cole J; Torres IJ; Arumugham SS; Keramatian K; Saraf G; Lam RW; Chakrabarty T; Yatham LN
    JAMA Netw Open; 2021 Mar; 4(3):e210963. PubMed ID: 33710288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Add-on high frequency deep transcranial magnetic stimulation (dTMS) to bilateral prefrontal cortex in depressive episodes of patients with major depressive disorder, bipolar disorder I, and major depressive with alcohol use disorders.
    Rapinesi C; Kotzalidis GD; Ferracuti S; Girardi N; Zangen A; Sani G; Raccah RN; Girardi P; Pompili M; Del Casale A;
    Neurosci Lett; 2018 Apr; 671():128-132. PubMed ID: 29454034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive outcomes of TMS treatment in bipolar depression: Safety data from a randomized controlled trial.
    Myczkowski ML; Fernandes A; Moreno M; Valiengo L; Lafer B; Moreno RA; Padberg F; Gattaz W; Brunoni AR
    J Affect Disord; 2018 Aug; 235():20-26. PubMed ID: 29631203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Transcranial Direct Current Stimulation as an Add-on Treatment for Bipolar Depression: A Randomized Clinical Trial.
    Sampaio-Junior B; Tortella G; Borrione L; Moffa AH; Machado-Vieira R; Cretaz E; Fernandes da Silva A; Fraguas R; Aparício LV; Klein I; Lafer B; Goerigk S; Benseñor IM; Lotufo PA; Gattaz WF; Brunoni AR
    JAMA Psychiatry; 2018 Feb; 75(2):158-166. PubMed ID: 29282470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy.
    Nahas Z; Kozel FA; Li X; Anderson B; George MS
    Bipolar Disord; 2003 Feb; 5(1):40-7. PubMed ID: 12656937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Deep Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: A Prospective Multicenter Randomized Double-Blind Placebo-Controlled Trial.
    Carmi L; Tendler A; Bystritsky A; Hollander E; Blumberger DM; Daskalakis J; Ward H; Lapidus K; Goodman W; Casuto L; Feifel D; Barnea-Ygael N; Roth Y; Zangen A; Zohar J
    Am J Psychiatry; 2019 Nov; 176(11):931-938. PubMed ID: 31109199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right ventrolateral and left dorsolateral 10 Hz transcranial magnetic stimulation as an add-on treatment for bipolar I and II depression: a double-blind, randomised, three-arm, sham-controlled study.
    Novák T; Kostýlková L; Bareš M; Renková V; Hejzlar M; Renka J; Baumann S; Laskov O; Klírová M
    World J Biol Psychiatry; 2024 Jun; 25(5):304-316. PubMed ID: 38785073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EEG synchronized left prefrontal transcranial magnetic stimulation (TMS) for treatment resistant depression is feasible and produces an entrainment dependent clinical response: A randomized controlled double blind clinical trial.
    George MS; Huffman S; Doose J; Sun X; Dancy M; Faller J; Li X; Yuan H; Goldman RI; Sajda P; Brown TR
    Brain Stimul; 2023; 16(6):1753-1763. PubMed ID: 38043646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression.
    Avery DH; Holtzheimer PE; Fawaz W; Russo J; Neumaier J; Dunner DL; Haynor DR; Claypoole KH; Wajdik C; Roy-Byrne P
    Biol Psychiatry; 2006 Jan; 59(2):187-94. PubMed ID: 16139808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial.
    Fitzgerald PB; Brown TL; Marston NA; Daskalakis ZJ; De Castella A; Kulkarni J
    Arch Gen Psychiatry; 2003 Oct; 60(10):1002-8. PubMed ID: 14557145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression.
    Fitzgerald PB; Benitez J; de Castella A; Daskalakis ZJ; Brown TL; Kulkarni J
    Am J Psychiatry; 2006 Jan; 163(1):88-94. PubMed ID: 16390894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial.
    O'Reardon JP; Solvason HB; Janicak PG; Sampson S; Isenberg KE; Nahas Z; McDonald WM; Avery D; Fitzgerald PB; Loo C; Demitrack MA; George MS; Sackeim HA
    Biol Psychiatry; 2007 Dec; 62(11):1208-16. PubMed ID: 17573044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmenting antidepressants with deep transcranial magnetic stimulation (DTMS) in treatment-resistant major depression.
    Berlim MT; Van den Eynde F; Tovar-Perdomo S; Chachamovich E; Zangen A; Turecki G
    World J Biol Psychiatry; 2014 Sep; 15(7):570-8. PubMed ID: 25050453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two Versus One High-Frequency Repetitive Transcranial Magnetic Stimulation Session per Day for Treatment-Resistant Depression: A Randomized Sham-Controlled Trial.
    Theleritis C; Sakkas P; Paparrigopoulos T; Vitoratou S; Tzavara C; Bonaccorso S; Politis A; Soldatos CR; Psarros C
    J ECT; 2017 Sep; 33(3):190-197. PubMed ID: 28072660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial.
    Levkovitz Y; Isserles M; Padberg F; Lisanby SH; Bystritsky A; Xia G; Tendler A; Daskalakis ZJ; Winston JL; Dannon P; Hafez HM; Reti IM; Morales OG; Schlaepfer TE; Hollander E; Berman JA; Husain MM; Sofer U; Stein A; Adler S; Deutsch L; Deutsch F; Roth Y; George MS; Zangen A
    World Psychiatry; 2015 Feb; 14(1):64-73. PubMed ID: 25655160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternate day dTMS combined with SSRIs for chronic treatment resistant depression: A prospective multicenter study.
    Tendler A; Gersner R; Roth Y; Zangen A
    J Affect Disord; 2018 Nov; 240():130-136. PubMed ID: 30071416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Add-on rTMS for medication-resistant depression: a randomized, double-blind, sham-controlled trial in Chinese patients.
    Su TP; Huang CC; Wei IH
    J Clin Psychiatry; 2005 Jul; 66(7):930-7. PubMed ID: 16013911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.